REFERENCES
- Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteremia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60 (5): 913–20.
- Kang Cl, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49 (2): 760–6
- Blot S, Vandewoude K, De Bacquer D, Colardyn F. Noso-comial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization Clin Infect Dis 2002; 34 (12): 1600–6.
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16 (3): 128–40.
- National Committee for Clinical Laboratory Standards. Per-formance standards for antimicrobial susceptibility testing. 14th informational supplement M100-514. Wayne, Pa, USA: Natio-nal Committee for Clinical Laboratory Standards; 2004.
- Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 2000.
- Kang Cl, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections due to extended-spectrum beta-lac-tamase-producing Escherichia coil and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special em-phasis on antimicrobial therapy. Antimicrob Agents Chemother 2004 ; 48 (12): 4574–81.
- Melzer M, Petersen I. Mortality following bacteraemic in-fection caused by extended spectrum beta-lactamase (ESBL) producing E. coil compared to non-ESBL producing E. coil. J Infect 2007; 55 (3): 254-9.
- Metan G, Zarakolu P, Cakir B, Hascelik G, Uzun O. Clini-cal outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Es-cherichia coil. Int J Antimicrob Agents 2005; 26 (3): 254-7.
- Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. Infection 2006; 34 (2): 66–74.
- O'Hara CM. Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-neg-ative bacilli. Clin Microbiol Rev 2005; 18 (1): 147–162.
- Donay JL, Mathieu D, Fernandes P, Preqermanin C, Bruel P, Warqnier A, et al. Evaluation of automated phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol 2004; 42 (4): 1542–6.
- Snyder JW, Munier GK, Johnson CL. Direct comparison of BD phoenix system with MicroScan Walkaway system for identification and antimicrobial susceptibility testing of Enter-obacteriaceae and nonfermentative gram-negative organisms. J Clin Microbiol 2008; 46 (7): 2327–33.
- Doi Y, Paterson DL. Detection of plasmid mediated class C beta-lactamases. Int J Antimicrob Agents 2007; 11: 191–7.
- Ding H, Yang Y, Lu 0, Wang Y, Chen C, Deng L, et al. The prevalence of plasmid mediated AmpC beta-lactamases among clinical isolates of Escherichia coil and Klebsiella pneu-monia from five children's hospital in China. Eur J Clin Micro-biol Infect Dis 2008; 27 (10): 915-21.
- Song W, Kim JS, Kim HS, Yong D, Jeong SH, Park MJ, et al. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromoso-mal ampC gene at Korean University Hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006; 55 (3): 219–224.
- Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22 (1): 161–182.
- Paterson DL, Bonomo RA. Extended-spectrum beta-lac-tamases: a clinical update. Clin Microbiol Rev 2005; 18: 657–86.
- Pitout JD, Le P, Church DL, Gregson DB, Laupland KB. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coil: failure of automated systems to detect resistance to piperacillin/tazobactam. Int J Antimicrob Agents 2008; 32: 333–38.